Page last updated: 2024-12-11

bis(3,5-dibromosalicyl)fumarate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bis(3,5-dibromosalicyl)fumarate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5997029
MeSH IDM0076835

Synonyms (29)

Synonym
2-butenedioic acid (e)-, bis(2,4-dibromo-6-carboxyphenyl) ester
3,5-dibromo-2-[(e)-4-(2,4-dibromo-6-carboxyphenoxy)-4-oxobut-2-enoyl]oxybenzoic acid
71337-53-6
bis (3,5-dibromosalicyl)fumarate
3,5-dibromosalicyl-bis-fumarate
0e07k30txy ,
bis(3,5-dibromosalicyl)fumarate
unii-0e07k30txy
2-butenedioic acid (2e)-, 1,4-bis(2,4-dibromo-6-carboxyphenyl) ester
dbsf
2-butenedioic acid(2e)-, 1,4-bis(2,4-dibromo-6-carboxyphenyl) ester
AKOS024374924
AC-24842
(e)-2,2'-(fumaroylbis(oxy))bis(3,5-dibromobenzoic acid)
c18h8br4o8
(z)-2,2'-(fumaroylbis(oxy))bis(3,5-dibromobenzoic acid)
161143-68-6
bis(3,5-dibromosal-icyl) fumarate
2,2'-(fumaroylbis(oxy))bis(3,5-dibromobenzoic acid)
387828-71-9
BS-17967
1,4-bis(2,4-dibromo-6-carboxyphenyl) (2e)-2-butenedioate
DTXSID301201183
AMY7471
Q27236652
(2e)-2-butenedioic acid bis(2,4-dibromo-6-carboxyphenyl)
(z)-2,2'-(fumaroylbis(oxy))bis(3,5-dibromobenzoicacid)
CS-0099486
PD194381
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (59)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (38.98)18.7374
1990's31 (52.54)18.2507
2000's5 (8.47)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.34 (24.57)
Research Supply Index4.09 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (15.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.39%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other57 (96.61%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]